Ropidoxuridine (C007B-415924)

Ropidoxuridine (IPdR) is a novel orally available, halogenated thymidine analog and is a potential radiosensitizer for use in human tumors.In VitroRopidoxuridine is an orally bioavailable pro-drug of IUdR (5-iodo-2'-deoxyuridine). Ropidoxuridine demonstrates strong synergy effects with Alisertib at clinically relevant concentrations. MCE has not independently confirmed the accuracy of these methods. They are for reference only.In VivoIn an orthotopic tumor model, Ropidoxuridine (750 mg/kg/day) and Alisertib (30 mg/kg/day) demonstrate strong synergy effects . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid. Specification: 0.99 Molecular Formula: C9H11IN2O4 Molecular Weight: 338.1 PubChem CID: 9840777 Isomeric SMILES: C1[C@@H]([C@H](O[C@H]1N2C=C(C=NC2=O)I)CO)O

UPC:

12142207

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

R650004-25mg

CAS:

93265-81-7

Product Size:

25mg